OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review
Juliane Liberto, Sheng-Yin Chen, Ie‐Ming Shih, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2885-2885
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Ovarian Cancer Screening: Where Do We Stand Now ?
Ikuo Konishi, Kaoru Abiko, Takuma Hayashi, et al.
Academia oncology. (2025) Vol. 2, Iss. 1
Closed Access | Times Cited: 1

High‐Valence Selenium Nanotherapeutics Downregulates MUC16 to Drive Precise Ovarian Cancer Therapy through Redox Perturbation
Xiaoli Hu, Zhongwen Yuan, Guanning Huang, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1

The influence of menopause age on gynecologic cancer risk: a comprehensive analysis using NHANES data
Yiliminuer Abulajiang, Tao Liu, Ming Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
Sebastian Stępień, Paweł Olczyk, Joanna Gola, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1118-1118
Open Access | Times Cited: 22

Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study
Minmin Wang, Yanxin Bi, Yinzi Jin, et al.
JCO Global Oncology (2024), Iss. 10
Closed Access | Times Cited: 6

Early Detection of Ovarian Cancer
Naoko Sasamoto, Kevin M. Elias
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 13, Iss. 11, pp. a041337-a041337
Closed Access | Times Cited: 13

Cancer Screening: Present Recommendations, the Development of Multi-Cancer Early Development Tests, and the Prospect of Universal Cancer Screening
Laurenţia Galeş, Mihai-Andrei Păun, Rodica Maricela Anghel, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1191-1191
Open Access | Times Cited: 5

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
Oluwaseun Adebayo Bamodu, Chen‐Chih Chung, Thomas R. Pisanic
The Journal of Liquid Biopsy (2023) Vol. 2, pp. 100126-100126
Open Access | Times Cited: 12

Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
Muttiah Barathan, Nur Dina Muhammad Fuad, Faizul Jaafar, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1806-1806
Open Access | Times Cited: 4

Molecularly Imprinted Polymers-based Biosensors for Gynecological Diagnostics and Monitoring
Faezeh Ghorbanizamani, Hichem Moulahoum, Figen Zihnioğlu, et al.
Talanta Open (2024), pp. 100364-100364
Open Access | Times Cited: 4

Harnessing Ensemble Deep Learning Models for Precise Detection of Gynaecological Cancers
Chetna Vaid Kwatra, Harpreet Kaur, Sai Prasad Potharaju, et al.
Clinical Epidemiology and Global Health (2025), pp. 101956-101956
Open Access

Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review)
Weijia Zhang, Yuqing Ding, Hui He, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-13
Open Access

Ovarian Cancer in Women with Intellectual Disability: Current Data
Brigitte Trétarre, Daniel Satgé
Cancers (2025) Vol. 17, Iss. 5, pp. 805-805
Open Access

Mass Spectrometry‐Based Proteomics for Next‐Generation Precision Oncology
Kuen‐Tyng Lin, Gul Muneer, Peirong Huang, et al.
Mass Spectrometry Reviews (2025)
Closed Access

MRI characteristics of FIGO stage IA epithelial ovarian cancer (EOC)
Yilin Wang, Yan Chen, Xinming Zhao, et al.
European Journal of Radiology (2025), pp. 112157-112157
Closed Access

Molecular Management of High-Grade Serous Ovarian Carcinoma
Paula Punzón-Jiménez, Víctor Lago, Santiago Domingo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13777-13777
Open Access | Times Cited: 18

A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination
Manrose Singh, Samantha Cornwell, Ariel Shaddaie, et al.
Gynecologic Oncology Reports (2024) Vol. 54, pp. 101417-101417
Open Access | Times Cited: 3

Anti-cancer activity of capsaicin and its analogs in gynecological cancers
Kathleen C. Brown, Amanda M. Sugrue, Kaitlyn Conley, et al.
Advances in cancer research (2024), pp. 241-281
Closed Access | Times Cited: 3

Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review
Sierra Silverwood, Grant Backer, Annie Galloway, et al.
BMJ Oncology (2024) Vol. 3, Iss. 1, pp. e000404-e000404
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top